Treatment of Community-acquired Pneumonia

This publication has 14 references indexed in Scilit:

• The development of macrolides: clarithromycin in perspective
  Journal of Antimicrobial Chemotherapy, 1991
• Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans
  Antimicrobial Agents and Chemotherapy, 1990
• Epidemiological features and chemotherapy of community-acquired respiratory tract infections
  Journal of Antimicrobial Chemotherapy, 1990
• New directions for macrolide antibiotics: structural modifications and in vitro activity
  Antimicrobial Agents and Chemotherapy, 1989
• Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria
  Antimicrobial Agents and Chemotherapy, 1987
• PROSPECTIVE STUDY OF THE AETIOLOGY AND OUTCOME OF PNEUMONIA IN THE COMMUNITY
  The Lancet, 1987
• Epidemiology of community-acquired respiratory tract infections in adults: Incidence, etiology, and impact
  The American Journal of Medicine, 1985
• Etiology of community-acquired pneumonia in patients requiring hospitalization
  European Journal of Clinical Microbiology & Infectious Diseases, 1985
• Erythromycin: A Microbial and Clinical Perspective After 30 Years of Clinical Use (First of Two Parts)
  Mayo Clinic Proceedings, 1985
• HOSPITAL STUDY OF ADULT COMMUNITY-ACQUIRED PNEUMONIA
  The Lancet, 1982